NANTKWEST (NK) Covered Calls

NANTKWEST covered calls NantKwest Incis a clinical-stage immunotherapy company focused on harnessing the power of the innate immune system by using the natural killer cell to treat cancer, infectious diseases and inflammatory diseases.

You can sell covered calls on NANTKWEST to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for NK (prices last updated Wed 4:16 PM ET):

NANTKWEST (NK) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
3.85 +0.04 3.85 4.33 106K - 0.3B
Covered Calls For NANTKWEST (NK)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jun 15 5 0.00 4.33 0.0% 0.0%
Jul 20 5 0.05 4.28 1.2% 7.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

NantKwest, Inc. develops and produces cancer treatment products based on its proprietary natural killer (NK) cell line, NK-92. It develops cell therapies for cancer, initially renal cell carcinoma and melanoma. The company was founded by Keller Gary N. and Klingemann Hans Georg on October 7, 2002 and is headquartered in Cardiff-by-the-Sea, CA.